Alx Oncology Holdings Inc (ALXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Sales | 1,182 | 4,796 | 2,067 | 0 | 0 |
| Cost of Goods | 1,075 | 4,360 | 1,880 | N/A | N/A |
| Gross Profit | 107 | 436 | 187 | N/A | N/A |
| Operating Expenses | 43,845 | 19,979 | 14,751 | 0 | 0 |
| Operating Income | -43,663 | -19,183 | -13,684 | N/A | N/A |
| Interest Expense | 0 | 21 | 0 | 0 | 0 |
| Other Income | -1,836 | -5 | -2 | 0 | 0 |
| Pre-tax Income | -45,499 | -19,209 | -13,686 | 0 | 0 |
| Income Tax | 241 | 34 | 45 | N/A | N/A |
| Net Income Continuous | -45,740 | -19,243 | -13,731 | N/A | N/A |
| Net Income | $-45,740 | $-19,243 | $-13,731 | $N/A | $N/A |
| EPS Basic Total Ops | -2.76 | -7.56 | -6.33 | N/A | N/A |
| EPS Basic Continuous Ops | -2.47 | -6.26 | -4.99 | N/A | N/A |
| EPS Diluted Total Ops | -2.76 | -7.56 | -6.33 | N/A | N/A |
| EPS Diluted Continuous Ops | -2.47 | -6.26 | -4.99 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -2.37 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-43,040 | $-18,743 | $-13,253 | $N/A | $N/A |